Kiora Pharmaceuticals, Inc. (KPRX)
NASDAQ: KPRX · Real-Time Price · USD
2.330
+0.010 (0.43%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Kiora Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -10.84 | 3.59 | -12.51 | -13.58 | -13.77 | Upgrade
|
| Depreciation & Amortization | 0.21 | 0.07 | 0.06 | 0.13 | 0.23 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0 | -0.03 | -0 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 4.62 | 2.11 | 1.9 | - | 4.04 | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.05 | -0.31 | - | - | - | Upgrade
|
| Stock-Based Compensation | 0.9 | 0.66 | 0.75 | 0.46 | 0.84 | Upgrade
|
| Other Operating Activities | -1.64 | -1.23 | 2.08 | 1.89 | -0.98 | Upgrade
|
| Change in Accounts Receivable | -0.92 | -0.6 | - | - | - | Upgrade
|
| Change in Accounts Payable | 1.12 | 0.23 | -0.81 | 0.78 | -0.31 | Upgrade
|
| Change in Unearned Revenue | 1.25 | - | - | - | - | Upgrade
|
| Change in Income Taxes | -1.49 | 1.63 | -0.55 | -0.87 | -0.44 | Upgrade
|
| Change in Other Net Operating Assets | -3.23 | 2.41 | -0.47 | 0.76 | -0.28 | Upgrade
|
| Operating Cash Flow | -9.96 | 8.56 | -9.56 | -10.43 | -10.68 | Upgrade
|
| Capital Expenditures | -0.11 | -0.01 | - | - | -0.06 | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0.01 | - | Upgrade
|
| Cash Acquisitions | - | - | - | - | -0.09 | Upgrade
|
| Investment in Securities | 14.54 | -22.66 | - | - | - | Upgrade
|
| Investing Cash Flow | 14.43 | -22.66 | - | 0.01 | -0.16 | Upgrade
|
| Short-Term Debt Issued | 2.75 | - | - | - | - | Upgrade
|
| Total Debt Issued | 2.75 | - | - | - | - | Upgrade
|
| Short-Term Debt Repaid | -2.75 | - | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | - | - | - | -0.21 | Upgrade
|
| Total Debt Repaid | -2.75 | - | - | - | -0.21 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | - | -0.21 | Upgrade
|
| Issuance of Common Stock | 0.27 | 16.69 | 7.27 | 5.9 | 17.8 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -0.02 | - | Upgrade
|
| Other Financing Activities | - | -1.19 | -1.31 | 2.74 | - | Upgrade
|
| Financing Cash Flow | 0.27 | 15.5 | 5.97 | 8.62 | 17.58 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.17 | -0.06 | 0.04 | -0.09 | -0.08 | Upgrade
|
| Net Cash Flow | 4.9 | 1.34 | -3.55 | -1.89 | 6.67 | Upgrade
|
| Free Cash Flow | -10.07 | 8.55 | -9.56 | -10.43 | -10.74 | Upgrade
|
| Free Cash Flow Margin | - | 53.39% | - | - | - | Upgrade
|
| Free Cash Flow Per Share | -2.42 | 2.07 | -17.76 | -128.16 | -400.88 | Upgrade
|
| Levered Free Cash Flow | -9.19 | 7.96 | -6.77 | -5.02 | -6.44 | Upgrade
|
| Unlevered Free Cash Flow | -9.18 | 7.97 | -6.76 | -5.01 | -6.43 | Upgrade
|
| Change in Working Capital | -3.27 | 3.67 | -1.82 | 0.67 | -1.04 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.